Poolbeg Pharma Past Performance

How has Poolbeg Pharma performed over the past 5 years?

[object Object] Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical Pharmaceuticals & Biotech annual earnings growth

Earnings and Revenue History

Quality Earnings: POLB is currently unprofitable.

Growing Profit Margin: POLB is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: Unable to establish if POLB's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare POLB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: POLB is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (5.6%).

Return on Equity

High ROE: POLB has a negative Return on Equity (-13.79%), as it is currently unprofitable.

Discover strong past performing companies